Related Experiment Video
Updated: May 11, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Quinolones for mycobacterial infections
Ethan Rubinstein1, Yoav Keynan
1Department of Internal Medicine and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada. erubinstein70@gmail.com
Fluoroquinolones (FQs) significantly shorten leprosy treatment. However, widespread resistance complicates their use in multidrug-resistant tuberculosis (MDR-TB), though newer agents show promise.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Fluoroquinolones (FQs) are crucial for treating mycobacterial infections.
- FQs have revolutionized leprosy treatment by shortening therapy duration.
- Their role in tuberculosis (TB) is challenged by increasing resistance.
Purpose of the Study:
- To evaluate the efficacy and role of fluoroquinolones in leprosy and tuberculosis.
- To assess the impact of fluoroquinolone resistance on treatment strategies.
- To explore the potential of novel fluoroquinolone-related compounds in drug-resistant TB.
Main Methods:
- Review of animal and human studies on fluoroquinolone use in leprosy.
- Analysis of fluoroquinolone resistance patterns in multidrug-resistant tuberculosis (MDR-TB) prevalent regions.
- Examination of emerging fluoroquinolone-related compounds like bedaquiline for TB treatment.
Main Results:
- Fluoroquinolones are established as a cornerstone therapy for leprosy.
- Widespread fluoroquinolone resistance is a significant challenge in treating MDR-TB, especially in Southeast Asia.
- Early human studies suggest potential efficacy of bedaquiline in drug-resistant TB.
Conclusions:
- Fluoroquinolones remain vital for leprosy treatment.
- Fluoroquinolone resistance necessitates alternative strategies for MDR-TB.
- Bedaquiline represents a potential new avenue for treating extensively drug-resistant tuberculosis (XDR-TB).
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Anthelminthic Agents
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
